United States Muscular Dystrophy Market and Competitive Landscape Highlights Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Muscular Dystrophy Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Muscular Dystrophy Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Muscular Dystrophy pipeline products, Muscular Dystrophy epidemiology, Muscular Dystrophy market valuations and forecast, Muscular Dystrophy products sales and competitive landscape in the US.

The research is classified into nine sections - Muscular Dystrophy overview including etiology, pathophysiology, and diagnosis, Muscular Dystrophy treatment options, Muscular Dystrophy pipeline products, Muscular Dystrophy market analysis comprising of Muscular Dystrophy epidemiology, key products marketed for Muscular Dystrophy, market valuations and forecast, products sales and market shares.

Research Scope:

  • Muscular Dystrophy Pipeline: Find out the products in clinical trials for the treatment of Muscular Dystrophy by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Muscular Dystrophy Epidemiology: Find out the number of patients diagnosed (prevalence) with Muscular Dystrophy in the US
  • Muscular Dystrophy Products: Identify key products marketed and prescribed for Muscular Dystrophy in the US, including trade name, molecule name, and company
  • Muscular Dystrophy Product Sales: Find out the sales revenues of Muscular Dystrophy products, both branded and generics, in the US
  • Muscular Dystrophy Market Valuations: Find out the market size for Muscular Dystrophy products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Muscular Dystrophy Products Market Share: Find out the market shares for key Muscular Dystrophy products in the US

Key Topics Covered:

  1. Disease Overview
  2. Muscular Dystrophy Treatments
  3. Muscular Dystrophy Pipeline
  4. US Muscular Dystrophy Epidemiology
  5. Marketed Drugs for Muscular Dystrophy in US
  6. US Muscular Dystrophy Market Size
  7. US Muscular Dystrophy Products Sales
  8. US Muscular Dystrophy Market Competitive Landscape
  9. US Muscular Dystrophy Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/2wlhcw/us_muscular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Musculoskeletal Disorders Drugs